Health Care • Hospital/Nursing Management
$49.68 ▲ +0.62
(+1.26%)
MKT CAP: $7.87B • VOL: 896.5K
52W L $10 52W H $50
PACS // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $5.29B | $4.09B | $3.11B |
| YoY Revenue Growth % | +29.4% | +31.4% | — |
| Gross Profit | $2.33B | $1.80B | $1.37B |
| Gross Margin % | 44.0% | 44.0% | 44.0% |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $309.6M | $123.1M | $207.8M |
| Operating Margin % | 5.9% | 3.0% | 6.7% |
| Net Income (GAAP) | $191.5M | $55.8M | $112.9M |
| EBITDA (Normalized) | $500.0M | $270.2M | $319.7M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $404.2M | $367.3M | $63.7M |
| Capital Expenditures (CapEx) | $238.0M | $183.9M | $140.0M |
| Free Cash Flow (FCF) | $166.3M | $183.4M | -$76.3M |
| FCF Margin % | 3.1% | 4.5% | -2.5% |
| Return on Invested Capital (ROIC %) | 24.6% | 12.1% | 6.3% |
| Cash & Short-Term Equivalents | $197.0M | $157.7M | $475.9M |
| Total Debt (Short + Long Term) | $244.8M | $251.0M | $1.01B |
| Total Stockholders' Equity | $946.8M | $709.6M | $2.08B |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR PACS.